Last reviewed · How we verify
Boswellia
At a glance
| Generic name | Boswellia |
|---|---|
| Sponsor | Medical University of South Carolina |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- The Effectiveness of a Herbal Supplement in Osteoarthritis. (NA)
- Flexy3 Supplementation and Joint Health (NA)
- Effect of Boswellia Serrata on Pain Intensity, Central and Peripheral Sensitization, and Pain Modulation in Healthy Volunteers (NA)
- Effects of Rosa Damascena and Frankincense Essential Oils in Labor (NA)
- A Study to Assess Efficacy of Supporting Properties and Safety of ARTNEO in Patients With Knee Osteoarthritis (NA)
- Herbal Irrigation in Necrotic Primary Molars (NA)
- Effect and Tolerance of Standardized Exclusive Dry Extracts of Curcuma Longa and of Boswellia Serrata Among People With Hand Joint Discomfort and Dysfunction (NA)
- Effects of Botanical Microglia Modulators in Gulf War Illness (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Boswellia CI brief — competitive landscape report
- Boswellia updates RSS · CI watch RSS
- Medical University of South Carolina portfolio CI